Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial [Yahoo! Finance]
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit [Yahoo! Finance]
Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]